The swiftly spreading COVID-19 pandemic may differentially affect individuals with primary immunodeficiencies (PIDs), who have variable infection risk, immune-dysregulation and report worse health-related quality of life (HRQoL) than the general population. Our objective was to assess the impact of COVID-19 on healthcare access, physical and mental health among adults with PIDs. METHODS: Using data from the ongoing Immune Deficiency Foundation longitudinal surveys [April-June 2020 (IRB exempt)] on individuals with PIDs that opted-in [;9% response-rate (2086/ 22,341 emails)], we included adults with available PROMIS global health/ HRQoL questions. New healthcare access problems during COVID-19 (immunoglobulin replacement (IgRT) delays, location/ product changes, medication issues or missed appointments) and resulting negative impact on physical/ mental health were analyzed using Chi-square (Fisher's exact)/ t-tests/ Mann-Whitney tests. RESULTS: Of the 565 adults included (;30% of adults that opted-in), majority were females [86% (485/561)] and antibody defects were the most common diagnosis [96% (543/565)]; 90% (507/565) on IgRT. While 63% (359/565) reported healthcare access problems, IgRT issues were infrequent [4% (23/565)]. Mean PROMIS global physical (39.6) and mental health scores (43.5) were below the national average (p <0.001) (longitudinal follow-up ongoing). Individuals with healthcare access problems more often reported a moderate-severe negative impact on their physical and mental health vs. those without access issues [84% (103/123) vs 58% (250/428), p< 0.01 and 70% (204/291) vs 57% (149/260), p< 0.01 respectively]. CONCLUSIONS: Healthcare access issues are common during COVID-19 and negatively impact physical and mental health among individuals with PIDs providing insight into potentially modifiable factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.